Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Work by Geronimus cited in account of Serena Williams' maternal health complications

Alexander and Massey compare outcomes for children whose parents did and did not take part in Great Migration

Geronimus on pushing past early dismissal of her weathering hypothesis

More News

Highlights

Robert Wood Johnson Foundation health leadership development programs accepting applications

AA named 2018 Best Place to Live in America (out of 100 cities)

Remembering Jim Morgan, founding member of ISR and creator of the PSID

1/17/18: ISR screening and discussion of documentary "Class Divide" at Michigan Theater

More Highlights

Next Brown Bag

Mon, Jan 22, 2018, noon: Narayan Sastry

Are antiseptic-coated central venous catheters effective in a real-world setting?

Publication Abstract

Borschel, D.M., C.E. Chenoweth, S.R. Kaufman, K.V. Hyde, K.A. VanDerElzen, Trivellore Raghunathan, C.D. Collins, and S. Saint. 2006. "Are antiseptic-coated central venous catheters effective in a real-world setting?" American Journal of Infection Control, 34(6): 388-393.

Background: Catheter-related bloodstream infections are common, costly, and morbid. Randomized controlled trials indicate that antiseptic-coated central venous catheters reduce infection rates.

Objective: To assess the clinical and economic effectiveness of antiseptic-coated catheters for critically ill patients in a real-world setting.

Methods: Central venous catheters coated with chlorhexidine/silver-sulfadiazene were introduced in all patients requiring central venous access in adult intensive care units at the University of Michigan Health System, a large, tertiary care teaching hospital. A pretest-post-test cohort design measured the primary outcome of catheter-related bloodstream infection rate, comparing the 2 years prior to the intervention with the 2 years following the intervention. We also evaluated cost-effectiveness and changes in vancomycin use.

Results: The intervention was associated with a 4% per month relative reduction in the incidence of catheter-related bloodstream infection, after controlling for the effects of time. Overall, a 35% relative risk reduction (P < .0003) in the catheter-related bloodstream infection rate occurred in the posttest phase. The use of antiseptic-coated catheters reduced costs more than $100,000 annually. Vancomycin use was less in units in which antiseptic catheters were used compared with wards in which these catheters were not used.

Conclusion: Antiseptic-coated catheters appear to be clinically effective and economically efficient in a real-world setting.

DOI:10.1016/j.ajic.2005.08.004 (Full Text)

Browse | Search : All Pubs | Next